Supreme Court Won't Hear Zoloft Patent Case Hinging on Declaratory Judgment

Drug Industry Daily
KEYWORDS courts / generic / Patents
A A

The U.S. Supreme Court has declined to review Teva Pharmaceutical’s long-running patent challenge to Pfizer’s antidepressant Zoloft — a case that hinges on the crucial declaratory judgment issue.

To View This Article:

Login

Subscribe To Drug Industry Daily